My Companies
Notification
Account
Log Out
Login
Gujarat Themis Biosyn closed its QIP, approving the issue of 2.12 crore equity shares to QIBs at ₹354 each, a 4.98% discount to the ₹372.57 floor price, raising approximately ₹75 crore. Context: first funding step toward the acquisition program.
Gujarat Themis Biosyn Opens QIP At ₹372.57 Floor Price
Gujarat Themis Biosyn Promoter's 47% Stake Fully Encumbered Indirectly
Gujarat Themis Biosyn Initiates ₹90 Crore Arbitration Against Optimus Drugs